Peer reviewed

Tirzepatide as compared with semaglutide for the treatment of obesity

Head-to-head randomized SURMOUNT-5 obesity trial.

New England Journal of MedicinePublished 2025Accessed 2026-07-12

Open original source

Registry record

Source metadata

Publisher
New England Journal of Medicine
Source type
Peer reviewed
Registry ID
nejm-surmount5-tirzepatide-semaglutide

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.